- Home
- BHRB vs KOD Comparison
BHRB vs KOD Comparison
Compare BHRB & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHRB
- KOD
- Stock Information
- Founded
- BHRB 1852
- KOD 2009
- Country
- BHRB United States
- KOD United States
- Employees
- BHRB N/A
- KOD N/A
- Industry
- BHRB Major Banks
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BHRB Finance
- KOD Health Care
- Exchange
- BHRB Nasdaq
- KOD Nasdaq
- Market Cap
- BHRB 940.0M
- KOD 795.5M
- IPO Year
- BHRB N/A
- KOD 2018
- Fundamental
- Price
- BHRB $61.26
- KOD $19.25
- Analyst Decision
- BHRB Strong Buy
- KOD Buy
- Analyst Count
- BHRB 3
- KOD 7
- Target Price
- BHRB $71.67
- KOD $19.29
- AVG Volume (30 Days)
- BHRB 41.4K
- KOD 952.6K
- Earning Date
- BHRB 10-23-2025
- KOD 11-13-2025
- Dividend Yield
- BHRB 3.61%
- KOD N/A
- EPS Growth
- BHRB 337.34
- KOD N/A
- EPS
- BHRB 8.48
- KOD N/A
- Revenue
- BHRB $331,053,000.00
- KOD N/A
- Revenue This Year
- BHRB $51.36
- KOD N/A
- Revenue Next Year
- BHRB $5.03
- KOD N/A
- P/E Ratio
- BHRB $7.18
- KOD N/A
- Revenue Growth
- BHRB 82.52
- KOD N/A
- 52 Week Low
- BHRB $47.57
- KOD $1.92
- 52 Week High
- BHRB $75.32
- KOD $20.13
- Technical
- Relative Strength Index (RSI)
- BHRB 52.31
- KOD 64.96
- Support Level
- BHRB $57.42
- KOD $16.25
- Resistance Level
- BHRB $62.58
- KOD $20.13
- Average True Range (ATR)
- BHRB 1.46
- KOD 1.70
- MACD
- BHRB 0.27
- KOD 0.34
- Stochastic Oscillator
- BHRB 74.42
- KOD 90.34
About BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.